Market closedNon-fractional

Terns Pharmaceuticals/TERN

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Terns Pharmaceuticals

Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases.

Ticker

TERN

Sector

Healthcare

Trading on

NASDAQ

Industry

Pharmaceuticals

Headquarters

Foster City, United States

Employees

66

TERN Metrics

BasicAdvanced
$444M
Market cap
-
P/E ratio
-$1.26
EPS
-0.50
Beta
-
Dividend rate
$444M
-0.5
27.854
27.26
0.18
-23.69%
-34.73%
1.86
1.86
-6.546
-12.92%
-46.86%

What the Analysts think about TERN

Analyst Ratings

Majority rating from 8 analysts.
Buy

TERN Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
0.00% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$0
NaN%
Net income
-$22M
6.19%
Profit margin
0.00%
NaN%

TERN Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 11.11%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.25
-$0.42
-$0.29
-$0.30
-
Expected
-$0.34
-$0.31
-$0.29
-$0.34
-$0.34
Surprise
-26.23%
37.45%
-0.76%
-11.11%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Terns Pharmaceuticals stock?

Terns Pharmaceuticals (TERN) has a market cap of $444M as of July 06, 2024.

What is the P/E ratio for Terns Pharmaceuticals stock?

The price to earnings (P/E) ratio for Terns Pharmaceuticals (TERN) stock is 0 as of July 06, 2024.

Does Terns Pharmaceuticals stock pay dividends?

No, Terns Pharmaceuticals (TERN) stock does not pay dividends to its shareholders as of July 06, 2024.

When is the next Terns Pharmaceuticals dividend payment date?

Terns Pharmaceuticals (TERN) stock does not pay dividends to its shareholders.

What is the beta indicator for Terns Pharmaceuticals?

Terns Pharmaceuticals (TERN) has a beta rating of -0.5. This means that it has an inverse relation to market volatility.

Buy or sell Terns Pharmaceuticals stock

Buy or sell Terns Pharmaceuticals stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing